| __timestamp | Ascendis Pharma A/S | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 21102000000 |
| Thursday, January 1, 2015 | 8118000 | 28633000000 |
| Friday, January 1, 2016 | 4606000 | 26129000000 |
| Sunday, January 1, 2017 | 1530000 | 21736000000 |
| Monday, January 1, 2018 | 10581000 | 17274000000 |
| Tuesday, January 1, 2019 | 13375000 | 17774000000 |
| Wednesday, January 1, 2020 | 6953000 | 20117000000 |
| Friday, January 1, 2021 | 4255000 | 20704000000 |
| Saturday, January 1, 2022 | 39037000 | 21624000000 |
| Sunday, January 1, 2023 | 222323000 | 20618000000 |
| Monday, January 1, 2024 | 319383000 | 78200000 |
Infusing magic into the data realm
In the ever-evolving landscape of biopharmaceuticals, Gilead Sciences, Inc. and Ascendis Pharma A/S present a fascinating study in contrasts. Over the past decade, Gilead Sciences has consistently demonstrated robust financial performance, with gross profits peaking in 2015 at approximately 33% higher than their 2014 figures. However, a gradual decline followed, with a 28% reduction by 2018, before stabilizing around the $20 billion mark in recent years.
Conversely, Ascendis Pharma, a relatively newer player, has shown a remarkable growth trajectory. From modest beginnings in 2014, their gross profit surged by an astounding 1,500% by 2023. This growth underscores Ascendis Pharma's strategic advancements and market penetration.
These trends highlight the dynamic nature of the biopharma sector, where established giants and emerging innovators coexist, each navigating their unique paths to success.
Gross Profit Trends Compared: Johnson & Johnson vs Gilead Sciences, Inc.
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. and Zoetis Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Gross Profit Trends Compared: Gilead Sciences, Inc. vs Perrigo Company plc
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Ascendis Pharma A/S vs Grifols, S.A.
Ascendis Pharma A/S and Alkermes plc: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends